Go Pro
TSE:RVX

Resverlogix (RVX) Stock Price, News & Analysis

Resverlogix logo
C$0.10 +0.01 (+5.26%)
As of 08/10/2026 03:32 PM Eastern

About Resverlogix Stock (TSE:RVX)

Advanced

Key Stats

Today's Range
C$0.10
C$0.10
50-Day Range
C$0.09
C$0.11
52-Week Range
C$0.09
C$0.15
Volume
27,000 shs
Average Volume
34,800 shs
Market Capitalization
C$31.70 million
P/E Ratio
N/A
Dividend Yield
7.02%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.

Receive RVX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Resverlogix and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RVX Stock News Headlines

Porter flew 3,300 miles to investigate this system
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.tc pixel
See More Headlines

RVX Stock Analysis - Frequently Asked Questions

Resverlogix's stock was trading at C$0.10 at the beginning of 2026. Since then, RVX stock has increased by 0.0% and is now trading at C$0.10.

Resverlogix Corp. (TSE:RVX) posted its quarterly earnings data on Friday, May, 15th. The biotechnology company reported $0.01 earnings per share for the quarter.

Shares of RVX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Resverlogix investors own include ProMetic Life Sciences (PLI), Aptose Biosciences (APTO), Antibe Therapeutics (ATE), Oncolytics Biotech (ONC), Radient Technologies (RTI), VentriPoint Diagnostics (VPT) and Burcon NutraScience (BU).

Company Calendar

Last Earnings
5/15/2026
Today
8/11/2026

Industry, Sector and Symbol

Stock Exchange
TSE
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
TSE:RVX
CIK
N/A
Fax
N/A
Employees
19
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.02)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$2.81 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
6.67%
Return on Assets
-34.90%

Debt

Debt-to-Equity Ratio
-83.11
Current Ratio
0.03
Quick Ratio
0.04

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
C$0.00 per share
Price / Cash Flow
132.50
Book Value
C($0.30) per share
Price / Book
-0.33

Miscellaneous

Outstanding Shares
316,978,000
Free Float
N/A
Market Cap
C$31.70 million
Optionable
Not Optionable
Beta
0.35
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (TSE:RVX) was last updated on 8/11/2026 by MarketBeat.com Staff.
From Our Partners